Goldman Sachs’s Tivity Health, Inc. Common Stock TVTY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-858,538
| Closed | -$27.6M | – | 6902 |
|
|
2022
Q1 | $27.6M | Sell |
858,538
-199,162
| -19% | -$5.39M | 0.01% | 1785 |
|
|
2021
Q4 | $28M | Sell |
1,057,700
-46,060
| -4% | -$1.17M | 0.01% | 1828 |
|
|
2021
Q3 | $25.5M | Buy |
1,103,760
+89,833
| +9% | +$2.13M | 0.01% | 1836 |
|
|
2021
Q2 | $26.7M | Sell |
1,013,927
-1,198,056
| -54% | -$30.1M | 0.01% | 1800 |
|
|
2021
Q1 | $49.4M | Sell |
2,211,983
-1,445,400
| -40% | -$33.1M | 0.01% | 1175 |
|
|
2020
Q4 | $71.6M | Sell |
3,657,383
-83,511
| -2% | -$1.39M | 0.02% | 838 |
|
|
2020
Q3 | $52.4M | Sell |
3,740,894
-184,348
| -5% | -$2.66M | 0.01% | 957 |
|
|
2020
Q2 | $44.5M | Sell |
3,925,242
-518,236
| -12% | -$4.73M | 0.01% | 1043 |
|
|
2020
Q1 | $27.9M | Buy |
4,443,478
+4,346,529
| +4,483% | +$70.1M | 0.01% | 1266 |
|
|
2019
Q4 | $1.97M | Sell |
96,949
-78,812
| -45% | -$1.47M | ﹤0.01% | 3658 |
|
|
2019
Q3 | $2.92M | Sell |
175,761
-72,696
| -29% | -$1.26M | ﹤0.01% | 3265 |
|
|
2019
Q2 | $4.08M | Sell |
248,457
-320,076
| -56% | -$6.18M | ﹤0.01% | 2991 |
|
|
2019
Q1 | $9.98M | Buy |
568,533
+293,891
| +107% | +$6.25M | ﹤0.01% | 2420 |
|
|
2018
Q4 | $6.81M | Sell |
274,642
-1,398
| -0.5% | -$46.5K | ﹤0.01% | 2633 |
|
|
2018
Q3 | $8.88M | Sell |
276,040
-85,345
| -24% | -$2.91M | ﹤0.01% | 2554 |
|
|
2018
Q2 | $12.7M | Sell |
361,385
-144,143
| -29% | -$5.32M | ﹤0.01% | 2224 |
|
|
2018
Q1 | $20M | Buy |
505,528
+347,894
| +221% | +$13.5M | 0.01% | 1856 |
|
|
2017
Q4 | $5.76M | Buy |
157,634
+74,694
| +90% | +$2.83M | ﹤0.01% | 2896 |
|
|
2017
Q3 | $3.38M | Buy |
82,940
+13,707
| +20% | +$531K | ﹤0.01% | 3506 |
|
|
2017
Q2 | $2.76M | Buy |
69,233
+3,162
| +5% | +$106K | ﹤0.01% | 3570 |
|
|
2017
Q1 | $1.92M | Sell |
66,071
-46,645
| -41% | -$1.23M | ﹤0.01% | 3780 |
|
|
2016
Q4 | $2.56M | Sell |
112,716
-52,442
| -32% | -$1.23M | ﹤0.01% | 3620 |
|
|
2016
Q3 | $4.37M | Buy |
165,158
+139,424
| +542% | +$2.81M | ﹤0.01% | 3156 |
|
|
2016
Q2 | $297K | Buy |
25,734
+11,469
| +80% | +$134K | ﹤0.01% | 5339 |
|
|
2016
Q1 | $144K | Buy |
+14,265
| New | +$160K | ﹤0.01% | 5863 |
|
|
2015
Q4 | – | Sell |
-13,203
| Closed | -$147K | – | 7434 |
|
|
2015
Q3 | $147K | Sell |
13,203
-5,308
| -29% | -$64.9K | ﹤0.01% | 6224 |
|
|
2015
Q2 | $222K | Sell |
18,511
-49,772
| -73% | -$826K | ﹤0.01% | 6053 |
|
|
2015
Q1 | $1.34M | Buy |
68,283
+54,411
| +392% | +$1.14M | ﹤0.01% | 4185 |
|
|
2014
Q4 | $276K | Sell |
13,872
-2,770
| -17% | -$45.2K | ﹤0.01% | 5868 |
|
|
2014
Q3 | $267K | Sell |
16,642
-14,836
| -47% | -$252K | ﹤0.01% | 5874 |
|
|
2014
Q2 | $552K | Buy |
31,478
+7,550
| +32% | +$130K | ﹤0.01% | 5222 |
|
|
2014
Q1 | $410K | Sell |
23,928
-99,274
| -81% | -$1.53M | ﹤0.01% | 5460 |
|
|
2013
Q4 | $1.89M | Buy |
+123,202
| New | +$1.75M | ﹤0.01% | 4124 |
|
Other funds holding TVTY
BCMLT
PP
IA
Goldman Sachs's TVTY Position: Q2 2022 in Review
Goldman Sachs sold out of Tivity Health, Inc. Common Stock (TVTY) in Q2 2022, closing a stake of 858,538 shares — an estimated $27.6M sold.
Goldman Sachs first reported a position in TVTY in Q4 2013 and held it in 33 quarters. The position peaked at $71.6M in Q4 2020. 4 funds tracked by Wall St. Rank hold TVTY as of Q2 2022.
- Goldman Sachs reported no remaining Tivity Health, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
- Goldman Sachs sold 858,538 Tivity Health, Inc. Common Stock shares in Q2 2022, an estimated $27.6M.
- Goldman Sachs first reported a position in Tivity Health, Inc. Common Stock in Q4 2013 and held it in 33 quarters.
- Goldman Sachs's Tivity Health, Inc. Common Stock position peaked at $71.6M in Q4 2020.
- 4 funds tracked by Wall St. Rank held Tivity Health, Inc. Common Stock as of Q2 2022.
Based on Goldman Sachs's 13F filing for Q2 2022, filed 15 Aug 2022.